Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre-Transplant Induction and Post-Transplant Consolidation in Newly Diagnosed Multiple Myeloma Patients

Francesca Gay, Wilfried Roeloffzen, Meletios Α. Dimopoulos, +25

Blood

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman, +31

The Lancet Haematology

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

Artur Jurczyszyn, Jakub Radocha, Julio Dávila, +31

British Journal of Haematology

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

Tomáš Jelı́nek, Renata Bezděková, David Žihala, +27

Journal of Clinical Oncology

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

Tomáš Jelı́nek, Tereza Ševčíková, David Žihala, +20

Leukemia

Hematological MalignancyMedicineMalignant Blood DisorderImmunologyHematology +6

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

Jiří Minařík, Petr Pavlíček, Luděk Pour, +20

PLoS ONE

Hematogenous extramedullary relapse in multiple myeloma ‐ a multicenter retrospective study in 127 patients

Irit Avivi, Yaël C. Cohen, Anna Suska, +19

American Journal of Hematology

PathologyHematogenous Extramedullary RelapseMyeloid NeoplasiaHematological MalignancyOncology +14

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

Jiří Minařík, Tomáš Pika, Jakub Radocha, +23

BMC Cancer

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

Sarah Goldman‐Mazur, Artur Jurczyszyn, Jorge J. Castillo, +40

American Journal of Hematology

ImmunologyPathologyImmunotherapyMyeloid NeoplasiaHematological Malignancy +15

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

Laurent Garderet, Simona Iacobelli, Linda Köster, +20

Biology of Blood and Marrow Transplantation

Third AsctCell TherapySurgeryHematological MalignancyOncology +14